Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Rivia logo — Know better. Act better.

Rivia

Know better. Act better.

Founded 2022 Switzerland Zurich, Switzerland 25 employees Series A Total: $16.00M

General Information

Company Name Rivia
Founded Year 2022
Location Switzerland Zurich, Switzerland +1
Employees 25
Funding Stage Series A
Social

Get notified when Rivia moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

In The News Sep 02, 2026

Featured on Eu-startups: UK startup Pharosyn raises €2.5 million for pharma competitive intelligence plat...

Get alerts when Rivia shows new signals

About Rivia

Rivia, founded in 2022 and headquartered in Switzerland, is a promising startup operating in the clinical trial intelligence sector. With its mission embodied in the slogan "Know better. Act better.", the Zurich-based company offers a sophisticated data engine aimed at innovating the approach to bringing new drugs to market.

In just two years, Rivia has made significant strides, with numerous European and US biotech firms utilizing its platform to enhance clinical trials. These collaborations have resulted in earlier understanding of therapeutic potentials and improved trial efficiency. As Rivia looks forward, it plans to scale its platform further to expedite the delivery of groundbreaking therapies to market.

To support its growth, Rivia secured a €13.00M Series A investment on 01 March 2026 from investors including Speedinvest, Earlybird, Nina Ventures, Amino Collective, and Defiant, highlighting investor confidence in its potential to transform the clinical trial landscape.

Taxonomy: clinical trial intelligence, data engine, clinical trial execution, therapeutic potential analysis, drug discovery, clinical operations, medical monitoring, biotech innovation, therapeutic innovators, clinical development, platform scaling, embedded intelligence, trial outcomes improvement, next-gen operating system

Services & Products

Rivia Core - Intelligence Layer
Rivia Detect - Data Quality Management
Rivia Spark - Visual Intelligence

Target Customers

Biopharma Companies Clinical Teams Executives in Healthcare Medical and Clinical Scientists Clinical Operations Personnel

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 5
Investor Investor Investor Investor
•••• •••• 		01 Mar 2026
Seed •••••• 3
Investor Investor Investor
01 Jun 2024

Latest News

View All
Zurich-based Rivia raises €3 million to address the critical inefficiencies in the current clinical... — Eu-startups
Zurich-based Rivia raises €3 million to address the critical inefficiencies in the current clinical trial process
Eu-startups Jun 12, 2024
Rivia raises €3M to handle data analytics for biotech companies — Tech
Rivia raises €3M to handle data analytics for biotech companies
Tech Jun 12, 2024
Zurich-based Rivia raises €13 million to power complex clinical trials with its agentic data engine — Eu-startups
Zurich-based Rivia raises €13 million to power complex clinical trials with its agentic data engine
Eu-startups Mar 18, 2026
Rivia raises €13M to bring agentic AI to clinical trials — Thenextweb
Rivia raises €13M to bring agentic AI to clinical trials
Thenextweb Mar 18, 2026
Rivia raises $15M to fix the broken data infrastructure behind clinical trials — Tech
Rivia raises $15M to fix the broken data infrastructure behind clinical trials
Tech Mar 18, 2026
Recap: Europe’s top funding rounds this week (16 -22 March) — Thenextweb
Recap: Europe’s top funding rounds this week (16 -22 March)
Thenextweb Mar 22, 2026

Rivia Alternatives & Competitors

View All Alternatives
Rivia vs
Lokavant
Lokavant United States

A Paradigm Shift in Clinical Trial Intelligence

Acquired
24 employees
AI, Data Analytics
Compare Rivia vs Lokavant
Rivia vs
Gen1 Research
Gen1 Research United States

Better care. It's necessary, and it's possible.

3 employees
Biotechnology, Health Care
Rivia vs
Sieve Health
Sieve Health United States

Leveraging AI technology to Accelerate Clinical Research

5 employees
AI, Health Care
Compare Rivia vs Sieve Health
Also compare with: Rivia vs Imperial Clinical Research Services Imperial Clinical Research Services View all alternatives

FAQ About Rivia

Know better. Act better.
Rivia was founded in 2022.
Rivia is headquartered in Zurich, Switzerland.
Rivia has approximately 25 employees.
Rivia has completed 2 funding rounds, raising a total of $16.00M. The latest funding stage is Series A.
Rivia offers: Rivia Core - Intelligence Layer, Rivia Detect - Data Quality Management, Rivia Spark - Visual Intelligence.
Top alternatives and competitors to Rivia include Lokavant, Gen1 Research, Sieve Health, Berry Consultants, LLC, Imperial Clinical Research Services. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rivia and Lokavant are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Rivia and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy